NLRC5 and melanoma: And it was also associated with DSS in GSE54467 (log-rank p = 0.019, Figure 2G), GSE53118 (log-rank p = 0.008, Figure 2H), and GSE65904 (log-rank p = 0.002, Figure 2I), indicating the close correlation between low expression of NLRC5 and poor outcomes of melanoma patients.